# OnCo record overtreatment (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/overtreatment/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "overtreatment" ;
  schema:name "Overtreatment"@en ;
  schema:alternateName "over-treatment"@en, "overtreatment of prostate cancer"@en, "unnecessary treatment"@en, "treatment of overdiagnosed cancer"@en ;
  schema:description "Treating a cancer that was never going to cause trouble. It is the harm that overdiagnosis causes: the diagnosis itself does not leak urine or end erections, the operation does. Published estimates of how much prostate cancer is overdiagnosed range from under 2 percent to two thirds, and the range is a fact about the methods, not about the disease."@en ;
  schema:url <https://onco.cc/terms/overtreatment/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Unnecessary_health_care> ;
  schema:citation <https://doi.org/10.1016/j.eururo.2013.12.062>, <https://doi.org/10.1093/jnci/djp001>, <https://doi.org/10.1093/jnci/djp278>, <https://doi.org/10.1001/jama.2018.3710>, <https://www.nice.org.uk/guidance/ng131/chapter/Recommendations> ;
  onco:tag "gu", "prostate-glossary" ;
  onco:related <https://onco.cc/terms/overdiagnosis/>, <https://onco.cc/terms/lead-time-bias/>, <https://onco.cc/terms/active-surveillance-term/>, <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/key-papers/paper-loeb-overdiagnosis-overtreatment-prostate-eur-urol-2014/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate-intermediate-risk/> ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/technologies/prostate-screening-psa-mri/> ;
  onco:terms <https://onco.cc/terms/overdiagnosis/>, <https://onco.cc/terms/lead-time-bias/>, <https://onco.cc/terms/number-needed-to-screen/>, <https://onco.cc/terms/screening/>, <https://onco.cc/terms/active-surveillance-term/>, <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/quality-of-life/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-overdiagnosis/>, <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-patient-voice/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-loeb-overdiagnosis-overtreatment-prostate-eur-urol-2014/>, <https://onco.cc/key-papers/paper-draisma-lead-time-overdiagnosis-psa-jnci-2009/>, <https://onco.cc/key-papers/paper-welch-albertsen-psa-era-diagnosis-treatment-jnci-2009/>, <https://onco.cc/key-papers/paper-uspstf-prostate-screening-jama-2018/> .